Cayla Mutter, PA
Medical · Bristol, TNNPI 1841849650
Payments from drug & device makers
Across 141 payments — averaging $28.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Novo Nordisk$440
- Dexcom, Inc.$277
- Lilly USA, LLC$240
- Boehringer Ingelheim$153
- Xeris Pharmaceuticals, Inc.$149
- plus $979 from 15 others
What the payments were for
- Travel & lodging$1,31732%
- Food & beverage$2,76068%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 24 | $1,840 |
| Novo Nordisk | 27 | $440 |
| Dexcom, Inc. | 13 | $277 |
| Lilly USA, LLC | 14 | $240 |
| Boehringer Ingelheim | 9 | $153 |
| Xeris Pharmaceuticals, Inc. | 7 | $149 |
| Abbott | 8 | $131 |
| Corcept Therapeutics | 6 | $129 |
| Tandem Diabetes Care, Inc. | 5 | $129 |
| Amgen | 4 | $86 |
| Insulet Corporation | 4 | $83 |
| Esperion Therapeutics, Inc. | 4 | $67 |
| Cequr Corporation | 1 | $63 |
| Bayer | 4 | $59 |
| Ascendis Pharma Endocrinology Inc | 3 | $56 |
| Sequel Med Tech, LLC | 1 | $47 |
| AbbVie | 3 | $45 |
| IBSA Pharma Inc. | 1 | $34 |
| BETA Bionics, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $17 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$1,345
How this compares
$4,076 in reported general payments places this provider in the 85th percentile of 480 medical providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 177 | $207,764 |
| OzempicSemaglutide | 140 | $192,944 |
| JardianceEmpagliflozin | 137 | $129,493 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 61 | $78,060 |
| Humalog Kwikpen U-200Insulin Lispro | 21 | $59,061 |
| TrulicityDulaglutide | 45 | $46,401 |
| Tresiba Flextouch U-200Insulin Degludec | 38 | $45,206 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 49 | $36,999 |
| FarxigaDapagliflozin Propanediol | 31 | $30,845 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 25 | $29,275 |
| Humalog Kwikpen U-100Insulin Lispro | 58 | $20,089 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $14,760 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 86 | $14,054 |
| Tresiba Flextouch U-100Insulin Degludec | 24 | $13,492 |
| JanumetSitagliptin Phos/Metformin Hcl | 14 | $11,415 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Humalog Mix 75-25, Insulin Lispro | $240 | $263,456265 claims |
| Novo NordiskOzempic, Novolog | $440 | $199,776156 claims |
| Boehringer IngelheimJardiance | $153 | $129,493137 claims |
| AbbVieSynthroid | $45 | $4,71361 claims |
| IBSA Pharma Inc.Tirosint | $34 | $1,60712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 480 medical providers in Tennessee.
Other medical in Bristol
- Dulcie ChampionBristol$5K
- Maria WoodChattanooga$130K
- Alyssa JamesonFranklin$65K
- Melissa LambertHendersonville$47K
- Stephanie HowardKnoxville$18K
- Evan HatfillNashville$18K
- Meredith McDanielChattanooga$17K
- Janet BreedingKnoxville$15K
- Paul MabenKnoxville$13K
- Hannah KirkGreeneville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.